ABO Blood Grouping Mismatch in Hematopoietic Stem Cell Transplantation and Clinical Guides

International Journal of Hematology-Oncology and Stem Cell Research

Gholamhossein Tamaddon¹  Negin Shokrgozar² 

[1] Diagnostic Laboratory Sciences and Technology Research Center, School of Paramedical Sciences, Shiraz University of Medical Sciences, Shiraz, Iran;School of Paramedical Sciences, Shiraz University of Medical Sciences, Shiraz, Iran;

关键词: Hematopoietic stem cell transplantation, Major ABO mismatch, Minor ABO mismatch, Transfusion strategy;   

DOI  :  10.18502/ijhoscr.v12i4.112

来源: DOAJ

【 摘 要 】

Hematopoietic stem cell transplantation (HSCT) is a useful treatment. In contrast to solid organ transplantations, the use of ABO blood group mismatch is acceptable in HSCT. Immediate or late hemolytic reactions, pure red cell aplasia, delayed red blood cell recovery, and graft-versus -host disease are the results of this situation. This review shows the consequences of ABO-mismatched HSCT and its impacts on HSCT parameters, as well as providing clinical guides in this situation.

【 授权许可】

Unknown